Today: 21 May 2026

Datadog stock swings in focus after Q4 beat, mixed 2026 outlook puts DDOG back on traders’ screens

Datadog stock swings in focus after Q4 beat, mixed 2026 outlook puts DDOG back on traders’ screens

Datadog reported fourth-quarter revenue up 29% to $953 million, beating estimates, but issued a first-quarter profit outlook below expectations. Shares rose in premarket trading. The company forecast first-quarter revenue of $951 million to $961 million and full-year revenue up to $4.10 billion. Investors await further detail on 2026 demand and margins at today’s call and Thursday’s investor day.
Upwork stock sinks about 26% in premarket after soft outlook jars investors (UPWK)

Upwork stock sinks about 26% in premarket after soft outlook jars investors (UPWK)

Upwork shares fell about 26% in premarket trading Tuesday to $13.92 after forecasting first-quarter revenue and profit below Wall Street estimates. The company beat fourth-quarter expectations but warned of a softer start to 2026. Active clients dropped to 785,000 at year-end. Upwork cited spending on enterprise and marketing as reasons for lower margin guidance.
TUI stock drops as summer bookings slip, muting record Q1 profit boost

TUI stock drops as summer bookings slip, muting record Q1 profit boost

TUI shares fell 3.5% to 9.02 euros in Frankfurt after the company reported slightly weaker booked revenue for summer 2026, despite its best first-quarter underlying EBIT since 2014. Booked revenue was down 2% for summer and 1% for winter 2025/26. TUI reaffirmed its full-year guidance and reported net debt improved to 3.6 billion euros. Investors focused on late-booking trends and profit delivery for the peak season.
10 February 2026
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health shares rose 3.3% to $12.66 in premarket trading after forecasting 2026 revenue of $18.7–$19.0 billion and operating earnings of $250–$450 million. The company posted a wider Q4 net loss of $353 million and a medical loss ratio of 95.4%. A U.S. House panel subpoenaed Oscar and other insurers over ACA subsidy practices. Oscar also disclosed a new $475 million revolving credit facility.
10 February 2026
Salesforce quietly cuts under 1,000 jobs as Agentforce AI unit gets hit

Salesforce quietly cuts under 1,000 jobs as Agentforce AI unit gets hit

Salesforce cut fewer than 1,000 jobs in early February, affecting marketing, product management, data analytics, and its Agentforce AI product, Business Insider reported. At least nine employees posted about the layoffs on LinkedIn, and two confirmed the cuts to the publication. The company is set to report quarterly results on Feb. 25. Salesforce did not respond to requests for comment.
10 February 2026
Bitcoin ATM scams are spooking lawmakers — new curbs on crypto kiosks and what victims should do fast

Bitcoin ATM scams are spooking lawmakers — new curbs on crypto kiosks and what victims should do fast

FBI data show Americans lost over $333 million to bitcoin ATM scams in 2025 as use of crypto kiosks surged. Lawmakers in at least 15 states have proposed tighter rules, while some cities consider bans. Operators and consumer groups urge stronger warnings and ID checks. In Houston, investigators report victims are often coached by scammers in real time at kiosks.
10 February 2026
Bitcoin price slips under $70,000 again as “buy the dip” gives way to “sell the rip”

Bitcoin price slips under $70,000 again as “buy the dip” gives way to “sell the rip”

Bitcoin hovered near $69,000 Tuesday after last week’s correction triggered $9 billion in liquidations and pushed more money into stablecoins, according to Kaiko. Analysts are divided on whether the shift from “buy the dip” to “sell the rally” signals a pause or deeper slide. Stablecoin dominance rose to 10.3% of crypto market cap. BlackRock’s iShares Bitcoin Trust ETF gained 1.2% to $40.11.
10 February 2026
Eddie Bauer bankruptcy: liquidation sales begin as 180-store operator seeks buyer

Eddie Bauer bankruptcy: liquidation sales begin as 180-store operator seeks buyer

Eddie Bauer’s store operator filed for Chapter 11 bankruptcy in New Jersey and began liquidation sales at about 180 U.S. and Canadian locations. The company listed $1.7 billion in debt and set a March 12 deadline for a court-approved sale. E-commerce and wholesale operations are not included in the filing. Most stores will remain open during the process, with closures possible if no buyer is found.
10 February 2026
Lithium price today holds near 136,000 yuan as China buying slows; miners lean on floor deals

Lithium price today holds near 136,000 yuan as China buying slows; miners lean on floor deals

Spot lithium carbonate prices in China edged up Tuesday, with SMM’s battery-grade index at 134,406 yuan a ton and trades averaging 136,000 yuan amid thin activity. Australia’s PLS Group signed a two-year spodumene supply deal with China’s Canmax, setting a $1,000-a-tonne floor and requiring a $100 million prepayment. Albemarle shares rose 1.4% to $165.76, while SQM slipped 0.4% to $71.15.
Heating oil price today: ULSD futures slip as Iran risk premium cools and U.S. stock data looms

Heating oil price today: ULSD futures slip as Iran risk premium cools and U.S. stock data looms

NYMEX heating oil futures fell 0.7% to $2.3996 a gallon in early Tuesday trade, tracking a pullback in crude after Monday’s gains tied to shipping risks near Iran. Brent crude slipped 24 cents to $68.80 a barrel. Traders await U.S. distillate inventory data due Wednesday. The U.S. issued new guidance for vessels near the Strait of Hormuz, fueling volatility.
US economic calendar today: Retail sales, import prices and a $58 billion Treasury auction set the tone for stocks

US economic calendar today: Retail sales, import prices and a $58 billion Treasury auction set the tone for stocks

U.S. stock index futures were flat early Tuesday ahead of December retail sales and trade price data due at 8:30 a.m. ET. The Dow, S&P 500, and Nasdaq all closed higher Monday, with the Dow hitting a second straight record. The NFIB small-business optimism index slipped to 99.3 in January. The Treasury will auction $58 billion in 3-year notes at 1 p.m. ET.
10 February 2026

Stock Market Today

  • Australia Shares Set to Rise at Open, New Zealand Markets Dip
    May 20, 2026, 7:49 PM EDT. Australian shares are expected to open higher, signaling investor confidence in the region's market outlook. In contrast, New Zealand equities are projected to decline at the open, reflecting differing economic or market responses. Market data sourced from ICE Data Services with reference information provided by FactSet, supported by multiple financial data providers. The divergence underscores the varied regional market trends in Oceania at the start of the trading session.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop